Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea · Delayed Price · Currency is KRW 1,660.00
-27.00 (-1.60%)
At close: Oct 30, 2026
Milae Bioresources Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,363 | 57,999 | 74,766 | 84,806 | 73,056 | 70,503 | |
Market Cap Growth | -48.92% | -22.43% | -11.84% | 16.08% | 3.62% | 32.38% |
Enterprise Value | 28,347 | 53,972 | 55,000 | 66,371 | 60,227 | 64,292 |
Last Close Price | 1660.00 | 2975.00 | 3835.00 | 4350.00 | 3850.00 | 3975.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 192.15 | 75.88 | 61.70 |
Forward PE | - | 32.36 | 32.36 | 32.36 | 32.36 | 32.36 |
PS Ratio | 0.45 | 0.86 | 1.20 | 1.41 | 0.97 | 1.06 |
PB Ratio | 0.81 | 1.36 | 1.64 | 1.92 | 1.79 | 2.13 |
P/TBV Ratio | 0.98 | 1.75 | 2.17 | 1.98 | 1.88 | 2.25 |
P/FCF Ratio | 120.73 | 14.50 | - | 32.58 | 103.42 | 28.75 |
P/OCF Ratio | 14.06 | 13.18 | - | 26.26 | 61.29 | 23.64 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.39 | 0.80 | 0.88 | 1.11 | 0.80 | 0.96 |
EV/EBITDA Ratio | 23.36 | 68.31 | 40.53 | 61.69 | 23.06 | 23.16 |
EV/EBIT Ratio | - | - | 299.34 | 3287.99 | 38.05 | 34.66 |
EV/FCF Ratio | 105.75 | 13.49 | - | 25.50 | 85.26 | 26.22 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.22 | 0.25 | 0.08 | 0.28 | 0.53 |
Debt / EBITDA Ratio | 8.97 | 12.06 | 8.48 | 3.46 | 4.33 | 6.26 |
Debt / FCF Ratio | 40.61 | 2.38 | - | 1.43 | 16.01 | 7.08 |
Net Debt / Equity Ratio | -0.10 | -0.16 | -0.06 | -0.49 | -0.39 | -0.31 |
Net Debt / EBITDA Ratio | -3.20 | -8.61 | -1.98 | -20.02 | -6.16 | -3.72 |
Net Debt / FCF Ratio | -14.48 | -1.70 | 2.52 | -8.27 | -22.77 | -4.22 |
Asset Turnover | 1.16 | 1.10 | 1.08 | 1.12 | 1.36 | 1.41 |
Inventory Turnover | 7.79 | 8.98 | 10.13 | 10.99 | 12.96 | 13.78 |
Quick Ratio | 1.27 | 1.64 | 1.56 | 4.64 | 2.45 | 4.87 |
Current Ratio | 1.72 | 2.11 | 1.96 | 5.32 | 2.81 | 5.59 |
Return on Equity (ROE) | -7.40% | -6.76% | -0.93% | 0.84% | 2.38% | 3.38% |
Return on Assets (ROA) | -0.97% | -1.47% | 0.20% | 0.02% | 1.77% | 2.46% |
Return on Invested Capital (ROIC) | -2.62% | -3.67% | 0.56% | 0.08% | 6.47% | 7.75% |
Return on Capital Employed (ROCE) | -2.30% | -3.30% | 0.40% | 0.00% | 3.80% | 3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -10.78% | -5.62% | -0.58% | 0.52% | 1.32% | 1.62% |
FCF Yield | 0.83% | 6.90% | -1.43% | 3.07% | 0.97% | 3.48% |
Buyback Yield / Dilution | -0.28% | - | -1.34% | -2.90% | -5.51% | 0.06% |